Table 3 Effect of Nicotinamide, Vitamin b2 and Vitamin C on hepatic MDA (nmol/mg), GSH (μmol/g tissue), catalase (U/g tissue), SOD (U/g tissue), NO (nmol/g,Hydroxyproline (Ug/g tissue) and plasma TNF-α (Pg/ml)

MDA

8.59 ± 0.42^a,b

9.04 ± 0.47^a,b

8.16 ± 0.32^a,b

7.35 ± 0.16^a,b,c

GSH

23.79 ± 0.51^a,b

23.55 ± 1.02^a,b

25.82 ± 0.54^a,b

29.48 ± 0.49^b,c

Catalase

400.46 ± 20.33^a,b

370.16 ± 12.93^a,b

395.00 ± 18.71^a,b

468.52 ± 8.75^b,c

SOD

200.17 ± 11.07^a,b

180.00 ± 4.51^a,b

188.72 ± 9.12^a,b

249.84 ± 8.26^b,c

NO

80.67 ± 3.74^a,b

93.08 ± 4.11^a,b

88.71 ± 3.53^a,b

74.96 ± 2.56^b

H.Prol

426.85 ± 10.65^a,b

512.67 ± 17.53^a,b

459.27 ± 13.89^a,b

342.79 ± 8.29^a,b,c

TNF-α

44.90 ± 0.56^a,b

60.85 ± 0.52^a,b

53.67 ± 0.36^a,b

36.42 ± 0.11^a,b,c